|
Volumn 29, Issue 36, 2000, Pages 2004-2008
|
Standards, options and recommendations for the use of hematopoietic growth factors in cancerology;Standards, options, recommandations pour l'utilisation des facteurs de croissance hematopoietique en cancerologie
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BLEOMYCIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
FLUOROURACIL;
HEMOPOIETIC GROWTH FACTOR;
IFOSFAMIDE;
MESNA;
METHOTREXATE;
MITOXANTRONE;
PREDNISONE;
PROCARBAZINE;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
VINCRISTINE;
VINDESINE;
ALGORITHM;
CANCER;
CANCER CHEMOTHERAPY;
CANCER PREVENTION;
FEBRILE NEUTROPENIA;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
PRACTICE GUIDELINE;
PRIMARY PREVENTION;
REVIEW;
SECONDARY PREVENTION;
TREATMENT PLANNING;
ANTINEOPLASTIC AGENTS;
COLONY-STIMULATING FACTORS;
FEVER;
HEMATOPOIETIC STEM CELL MOBILIZATION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
NEOPLASMS;
NEUTROPENIA;
PRACTICE GUIDELINES;
|
EID: 0034715834
PISSN: 07554982
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (7)
|
References (0)
|